Clinical Trials Logo

Popliteal Artery Stenosis clinical trials

View clinical trials related to Popliteal Artery Stenosis.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06410313 Not yet recruiting - Clinical trials for Superficial Femoral Artery Stenosis

First In Human Study to Assess Safety and Efficacy of the ChampioNIRâ„¢ Drug Eluting Peripheral Stent in the Treatment of Patients With Superficial Femoral Artery Disease and/or Proximal Popliteal Artery Disease

CHAMPIONSHIP
Start date: July 15, 2024
Phase: N/A
Study type: Interventional

This is a prospective, open label, multicenter, single arm, first in human clinical study. Patients with infra-inguinal peripheral arterial disease appropriate for treatment with a femoro-popliteal stent will be enrolled. The patients will be treated with the ChampioNIR Stent System. All implanted patients will be followed up at 30 days and 6, 12, 24 and 36 months. The follow-up visits will include patency evaluation by duplex ultrasound

NCT ID: NCT04175197 Not yet recruiting - Clinical trials for Peripheral Arterial Disease

LegDeb2 Global Registry for Use of Legflow in Peripheral Arteries

LEGDEB2
Start date: November 2019
Phase:
Study type: Observational

LEGDEB2 is a Global Registry for the Treatment of Superficial Femoral and/or Popliteal or Below-The-Knee or Iliac Artery Lesions Using the Legflow Drug-Eluting Balloon